Integrated analysis of overall survival from two multicenter randomized trials of 5-fluorouracil (5-FU) and leucovorin (LV) with or without trimetrexate (TMTX) in patients with advanced colorectal cancer (ACC)

Autor:	J.J. Schulz, J.V. Cox, G. Koch, W. Oster, C.J.A. Punt, Charles D. Blanke, T. Skovsgaard, H.J. Keizer, Daniel G. Haller, J. Schueller
Rok vydání:	2001
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry law.invention Advanced colorectal cancer Trimetrexate Randomized controlled trial Fluorouracil law Internal medicine Overall survival Medicine In patient business medicine.drug
Zdroj:	European Journal of Cancer. 37:S291-S292
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(01)81567-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::243c08eaafedfb4f51c6584fce28a325 https://doi.org/10.1016/s0959-8049(01)81567-7 Zobrazit plný text záznamu Full Text from ScienceDirect